Clinical Trial Update: Ecopipam Treatment of Tourette Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Ecopipam was studied in Phase 1 and Phase 2 trials for Tourette syndrome, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• Ecopipam (Ecopipam)

Snippet

Sponsor: Psyadon Pharma | Conditions: Tourette's Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-09-29